ArticleThe international journal of neuropsychopharmacology2020

The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.